Literature DB >> 12520007

Human immunodeficiency virus reverse transcriptase and protease sequence database.

Soo-Yon Rhee1, Matthew J Gonzales, Rami Kantor, Bradley J Betts, Jaideep Ravela, Robert W Shafer.   

Abstract

The HIV reverse transcriptase and protease sequence database is an on-line relational database that catalogues evolutionary and drug-related sequence variation in the human immunodeficiency virus (HIV) reverse transcriptase (RT) and protease enzymes, the molecular targets of antiretroviral therapy (http://hivdb.stanford.edu). The database contains a compilation of nearly all published HIV RT and protease sequences, including submissions to GenBank, sequences published in journal articles and sequences of HIV isolates from persons participating in clinical trials. Sequences are linked to data about the source of the sequence, the antiretroviral drug treatment history of the person from whom the sequence was obtained and the results of in vitro drug susceptibility testing. Sequence data on two new molecular targets of HIV drug therapy--gp41 (cell fusion) and integrase--will be added to the database in 2003.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12520007      PMCID: PMC165547          DOI: 10.1093/nar/gkg100

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  11 in total

1.  Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries.

Authors:  R W Shafer; D R Jung; B J Betts
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

2.  Diversity and complexity of HIV-1 drug resistance: a bioinformatics approach to predicting phenotype from genotype.

Authors:  Niko Beerenwinkel; Barbara Schmidt; Hauke Walter; Rolf Kaiser; Thomas Lengauer; Daniel Hoffmann; Klaus Korn; Joachim Selbig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

3.  Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes.

Authors:  Jay A Grobler; Kara Stillmock; Binghua Hu; Marc Witmer; Peter Felock; Amy S Espeseth; Abigail Wolfe; Melissa Egbertson; Michele Bourgeois; Jeffrey Melamed; John S Wai; Steve Young; Joseph Vacca; Daria J Hazuda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

4.  Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel.

Authors:  M S Hirsch; F Brun-Vézinet; R T D'Aquila; S M Hammer; V A Johnson; D R Kuritzkes; C Loveday; J W Mellors; B Clotet; B Conway; L M Demeter; S Vella; D M Jacobsen; D D Richman
Journal:  JAMA       Date:  2000-05-10       Impact factor: 56.272

5.  A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1.

Authors:  C J Petropoulos; N T Parkin; K L Limoli; Y S Lie; T Wrin; W Huang; H Tian; D Smith; G A Winslow; D J Capon; J M Whitcomb
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

6.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database: an expanded data model integrating natural language text and sequence analysis programs.

Authors:  R Kantor; R Machekano; M J Gonzales; K Dupnik; J M Schapiro; R W Shafer
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

Review 8.  Genotypic testing for human immunodeficiency virus type 1 drug resistance.

Authors:  Robert W Shafer
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

9.  A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugs.

Authors:  K Hertogs; M P de Béthune; V Miller; T Ivens; P Schel; A Van Cauwenberge; C Van Den Eynde; V Van Gerwen; H Azijn; M Van Houtte; F Peeters; S Staszewski; M Conant; S Bloor; S Kemp; B Larder; R Pauwels
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

10.  The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.

Authors:  J Michael Kilby; Jacob P Lalezari; Joseph J Eron; Margrit Carlson; Calvin Cohen; Roberto C Arduino; Jeffrey C Goodgame; Joel E Gallant; Paul Volberding; Robert L Murphy; Fred Valentine; Michael S Saag; Emily L Nelson; Prakash R Sista; Alex Dusek
Journal:  AIDS Res Hum Retroviruses       Date:  2002-07-01       Impact factor: 2.205

View more
  372 in total

1.  Emerging trends of drug-resistant HIV-1 among drug-treated patients in former blood donors in Hubei, China: a three-year surveillance from 2004 to 2006.

Authors:  Jian Gong; Xiao-Qiong Wang; Xiao Tong; Xi-Hui Shen; Rong-Ge Yang
Journal:  Virol Sin       Date:  2011-12-10       Impact factor: 4.327

2.  Drug resistance mutations in HIV pol sequences from Argentinean patients under antiretroviral treatment: subtype, gender, and age issues.

Authors:  Leandro R Jones; Franco Moretti; Andrea Y Calvo; Darío A Dilernia; Julieta M Manrique; Manuel Gómez-Carrillo; Horacio Salomón
Journal:  AIDS Res Hum Retroviruses       Date:  2011-11-22       Impact factor: 2.205

3.  Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypes.

Authors:  Niko Beerenwinkel; Martin Däumer; Mark Oette; Klaus Korn; Daniel Hoffmann; Rolf Kaiser; Thomas Lengauer; Joachim Selbig; Hauke Walter
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

4.  Evolution of resistance to drugs in HIV-1-infected patients failing antiretroviral therapy.

Authors:  Rami Kantor; Robert W Shafer; Stephen Follansbee; Jonathan Taylor; David Shilane; Leo Hurley; Dong-Phuong Nguyen; David Katzenstein; W Jeffrey Fessel
Journal:  AIDS       Date:  2004-07-23       Impact factor: 4.177

5.  Endogenous or exogenous spreading of HIV-1 in Nordrhein-Westfalen, Germany, investigated by phylodynamic analysis of the RESINA Study cohort.

Authors:  Glenn Lawyer; Eugen Schülter; Rolf Kaiser; Stefan Reuter; Mark Oette; Thomas Lengauer
Journal:  Med Microbiol Immunol       Date:  2012-01-20       Impact factor: 3.402

Review 6.  The HIVdb system for HIV-1 genotypic resistance interpretation.

Authors:  Michele W Tang; Tommy F Liu; Robert W Shafer
Journal:  Intervirology       Date:  2012-01-24       Impact factor: 1.763

7.  Directed HIV-1 evolution of protease inhibitor resistance by second-generation short hairpin RNAs.

Authors:  Nick C T Schopman; Anja Braun; Ben Berkhout
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

8.  Panel of prototypical recombinant infectious molecular clones resistant to nevirapine, efavirenz, etravirine, and rilpivirine.

Authors:  Maya Balamane; Vici Varghese; George L Melikian; W Jeffrey Fessel; David A Katzenstein; Robert W Shafer
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

9.  HIV-1 protease mutations and protease inhibitor cross-resistance.

Authors:  Soo-Yon Rhee; Jonathan Taylor; W Jeffrey Fessel; David Kaufman; William Towner; Paolo Troia; Peter Ruane; James Hellinger; Vivian Shirvani; Andrew Zolopa; Robert W Shafer
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

10.  Web resources for HIV type 1 genotypic-resistance test interpretation.

Authors:  Tommy F Liu; Robert W Shafer
Journal:  Clin Infect Dis       Date:  2006-04-28       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.